Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory Biomarkers in Atrial Fibrillation.
Zacharia E, Papageorgiou N, Ioannou A, Siasos G, Papaioannou S, Vavuranakis M, Latsios G, Vlachopoulos C, Toutouzas K, Deftereos S, Providência R, Tousoulis D. Zacharia E, et al. Among authors: papageorgiou n. Curr Med Chem. 2019;26(5):837-854. doi: 10.2174/0929867324666170727103357. Curr Med Chem. 2019. PMID: 28748764 Review.
Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
Stefanadi E, Tousoulis D, Antoniades C, Katsi V, Bosinakou E, Vavuranakis E, Triantafyllou G, Marinou K, Tsioufis C, Papageorgiou N, Latsios G, Stefanadis C. Stefanadi E, et al. Among authors: papageorgiou n. Int J Cardiol. 2009 Apr 3;133(2):266-8. doi: 10.1016/j.ijcard.2007.11.025. Epub 2008 Jan 9. Int J Cardiol. 2009. PMID: 18187214 Clinical Trial.
Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
Tousoulis D, Andreou I, Tentolouris C, Antoniades C, Papageorgiou N, Gounari P, Kotrogiannis I, Miliou A, Charakida M, Trikas A, Stefanadis C. Tousoulis D, et al. Among authors: papageorgiou n. Int J Cardiol. 2010 Dec 3;145(3):438-43. doi: 10.1016/j.ijcard.2009.05.051. Epub 2009 Jun 17. Int J Cardiol. 2010. PMID: 19539384 Clinical Trial.
Essential hypertension: is there a role for inflammatory mechanisms?
Androulakis ES, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C. Androulakis ES, et al. Among authors: papageorgiou n. Cardiol Rev. 2009 Sep-Oct;17(5):216-21. doi: 10.1097/CRD.0b013e3181b18e03. Cardiol Rev. 2009. PMID: 19690472 Review.
Is there a role for erythropoietin in cardiovascular disease?
Vogiatzi G, Briasoulis A, Tousoulis D, Papageorgiou N, Stefanadis C. Vogiatzi G, et al. Among authors: papageorgiou n. Expert Opin Biol Ther. 2010 Feb;10(2):251-64. doi: 10.1517/14712590903547819. Expert Opin Biol Ther. 2010. PMID: 20028188 Review.
288 results